Vaccines,
Journal Year:
2024,
Volume and Issue:
12(8), P. 886 - 886
Published: Aug. 4, 2024
This
study
presents
a
framework
for
determining
the
prioritization
of
vaccine
introduction
in
National
Immunization
Program
(NIP)
Republic
Korea,
with
focus
on
case
examples
assessed
2021
and
2023.
We
describe
predefined
criteria
evaluating
vaccines
NIP
established
process
Korea.
These
included
disease
characteristics,
rationality
efficiency
resource
allocation,
acceptance
immunization.
The
prioritizing
involved
several
sequential
steps:
demand
survey,
evidence
collection,
preliminary
evaluation,
priority
decision
making.
In
2023,
14
25
committee
members
participated
NIP,
respectively.
Overall,
13
19
candidates
were
2023
evaluations,
Through
Delphi
survey
consensus
processes,
order
was
determined:
vaccination
against
Rotavirus
infection
top
2021,
while
Influenza
4v
(for
chronic
patients)
took
precedence
demonstrates
an
evidence-based
decision-making
within
healthcare
field.
outlined
approach
may
provide
valuable
guidance
policymakers
other
countries
seeking
to
prioritize
inclusion
new
their
NIP.
Pharmaceutics,
Journal Year:
2024,
Volume and Issue:
16(11), P. 1360 - 1360
Published: Oct. 24, 2024
Over
80%
of
the
world's
deadliest
pandemics
are
caused
by
viral
infections,
and
vaccination
remains
most
effective
way
to
prevent
these
infections
from
spreading.
Since
discovery
first
vaccine
over
two
centuries
ago,
several
design
technologies
have
been
developed.
Next-generation
vaccines,
based
on
mRNA
vector
technologies,
recently
emerged
as
alternatives
traditional
vaccines.
Adenoviral
vector-based
vaccines
against
coronavirus
disease
2019
demonstrated
a
more
sustained
antibody
response
compared
However,
this
has
not
without
complications,
with
few
cases
severe
adverse
events
identified
in
vaccinated
individuals,
underlying
mechanism
is
subject
intense
investigation.
Adeno-associated
vectors
induce
weaker
cellular
immune
adenoviral
vectors,
it
mainly
for
reason
that
there
diminished
interest
exploring
them
platform
until
recently.
This
review
will
discuss
recent
developments
potential
adeno-associated
anti-viral
Frontiers in Public Health,
Journal Year:
2024,
Volume and Issue:
12
Published: Feb. 29, 2024
Introduction
Addresing
vaccine
hesitancy
is
considered
an
important
goal
in
management
of
the
COVID-19
pandemic.
We
sought
to
understand
what
factors
influenced
people,
especially
those
initially
hesitant,
receive
two
or
more
doses
within
a
year
vaccine’s
release.
Methods
conducted
longitudinal
Web-based
observational
studies
3,870
individuals.
The
surveys
were
at
four
different
time
points:
January
2021,
June
September
and
December
2021.
In
baseline
survey
(January
2021),
we
assessed
vaccination
intention
(i.e.,
“strongly
agree”
“agree”
[acceptance],
“neutral”
[not
sure],
“disagree”
disagree”
[hesitance]),
assumptions
about
coronavirus
disease
(COVID-19),
vaccine,
COVID-19-related
health
preventive
behavior,
reliability.
subsequent
(December
completion
≥2
vaccinations).
To
investigate
relationship
between
predictors
completion,
multivariable
logistic
regression
model
was
applied.
Adjusted
odds
ratios
(AORs)
95%
confidence
intervals
(CIs)
calculated
while
adjusting
for
gender,
age,
marital
status,
presence
children,
household
income
category,
diseases
under
treatment.
stratified
analysis,
determined
based
on
intention.
Results
Approximately
96,
87,
72%
who
demonstrated
acceptance,
not
sure,
hesitated
had
been
vaccinated
after
1
year,
respectively.
Overall,
significant
associated
with
compliance
included
influence
others
close
index
participant
(social
norms)
(AOR,
1.80;
CI,
1.56–2.08;
p
<
0.001),
1.39;
1.18–1.64;
0.001)
structural
constraints
(no
time,
inconvenient
location
medical
institutions,
other
related
factors)
0.80;
0.70–0.91;
=
0.001).
group
individuals
classified
as
social
norms
2.43;
1.83–3.22;
1.44;
1.10–1.88;
0.008),
knowledge
0.69;
0.53–0.88;
0.003).
Discussion
found
that
dissemination
accurate
information
vaccines
reduction
barriers
extent
possible
enhanced
rates.
Once
need
becomes
widespread,
it
norm,
further
improvements
these
rates
can
then
be
anticipated.
Our
findings
may
help
enhance
uptake
future.
Vaccines,
Journal Year:
2024,
Volume and Issue:
12(8), P. 886 - 886
Published: Aug. 4, 2024
This
study
presents
a
framework
for
determining
the
prioritization
of
vaccine
introduction
in
National
Immunization
Program
(NIP)
Republic
Korea,
with
focus
on
case
examples
assessed
2021
and
2023.
We
describe
predefined
criteria
evaluating
vaccines
NIP
established
process
Korea.
These
included
disease
characteristics,
rationality
efficiency
resource
allocation,
acceptance
immunization.
The
prioritizing
involved
several
sequential
steps:
demand
survey,
evidence
collection,
preliminary
evaluation,
priority
decision
making.
In
2023,
14
25
committee
members
participated
NIP,
respectively.
Overall,
13
19
candidates
were
2023
evaluations,
Through
Delphi
survey
consensus
processes,
order
was
determined:
vaccination
against
Rotavirus
infection
top
2021,
while
Influenza
4v
(for
chronic
patients)
took
precedence
demonstrates
an
evidence-based
decision-making
within
healthcare
field.
outlined
approach
may
provide
valuable
guidance
policymakers
other
countries
seeking
to
prioritize
inclusion
new
their
NIP.
